Discover why Editas Medicine (EDIT) targets high LDL cholesterol with in-the-body gene editing. Click here to read my most ...

Maya Ajmera, President & CEO of the Society for Science and Executive Publisher of Science News, spoke with David R. Liu, Thomas Dudley Cabot Professor of ...

One of the most revolutionary tools in cutting-edge medicine is a molecular scalpel so precise that it can modify defective ...

Two recent studies identified gene knockouts that may make CAR T-cell therapy more effective, but the next step is applying ...

LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- What Is The Expected Cagr For The Rare Disease Genome Editing Market Through 2025? The market size of genome editing for ...

As a result, the technology stands at a complicated intersection in the fight against a shifting climate. Breeding plants to ...

CRISPR Therapeutics’ stock is surging as in-vivo therapies show promise. Learn about CRSP stock's risks, long-term upside, ...

In the latest close session, CRISPR Therapeutics AG (CRSP) was down 6.54% at $68.29. The stock trailed the S&P 500, which registered a daily gain of 1.56%. On the other hand, the Dow registered a gain ...

As investors crowd into AI names at record highs, these three healthcare stocks offer more compelling valuations.

Twisted graphene precisely aligned with gold nanodisks and coupled with CRISPR achieves attomolar detection of cancer ...

Two scientists won the 2020 Nobel Prize in Chemistry on Wednesday for creating genetic 'scissors' that can rewrite the code of life, contributing to new cancer therapies and holding out the prospect ...

The idea that a single-celled bacterium can defend itself against viruses in a similar way as the 1.8-trillion-cell human immune system is still “mind-blowing” for molecular biologist Joshua Modell of ...